Ethosomes as delivery system for transdermal administration of vinpocetine

Pharmazie

Volumn 68, Issue 5, 2013, Pages 381-382

  Mao, Yan Ting ^a   Hua, Hai Ying ^a   Zhang, Xiang Guo ^a   Zhu, Dong Xue ^a   Li, Feng ^a   Gui, Zhen Hua ^a   Zhao, Yong Xing ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; ETHOSOME; UNCLASSIFIED DRUG; VINPOCETINE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; ENCAPSULATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; RAT; SKIN ABSORPTION; SKIN PERMEABILITY; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; INTUBATION, GASTROINTESTINAL; LIPOSOMES; RATS; RATS, SPRAGUE-DAWLEY; SOLUTIONS; VINCA ALKALOIDS;

EID: 84878408063     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2204     Document Type: Article

References (14)

1. Bendas ER, Tadros MI (2007) Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS Pharm Sci Tech 8:E107.
2. Bereczki D, Fekete I (1999) A systematic review of vinpocetine therapy in acute ischaemic stroke. Eur J Clin Pharmacol 55: 349-352. (Pubitemid 29344077)
3. Bhalaria MK, Naik S, Misra AN (2009) Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol 47: 368-375.
4. Dubey V, Mishra D, Jain NK (2007) Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 67: 398-405. (Pubitemid 47211909)
5. E. Touito, L. Bergelson, B. Godin, M. Eliaz (2000) Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release 65: 403-418. (Pubitemid 30122942)
6. El-Laithy HM, Shoukry O, Mahran LG (2011) Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77: 43-55.
7. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C (2005) Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22: 2163-2173. (Pubitemid 41821596)
8. Feigin VL, Doronin BM, Popova TF, Gribatcheva EV, Tchervov DV (2001) Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur J Neurol 8: 81-85. (Pubitemid 32154579)
9. Higashiyama M, Inada K, Ohtori A, Tojo K (2004) Improvement of the ocular bioavailability of timolol by sorbic acid. Int J Pharm 272: 91-98. (Pubitemid 38293014)
10. Hua L, Weisan P, Jiayu L, Hongfei L (2004) Preparation and evaluation of microemulsion of vinpocetine for transdermal delivery. Pharmazie 59: 274-278. (Pubitemid 38480715)
11. Jia-You Fang S-YY, Pao-Chu Wu, Yaw-Bin Huang, Yi-Hung Tsai (2001) in vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215: 91-99.
12. Liu X, Liu H, Liu J, He Z, Ding C, Huang G, Zhou W, Zhou L (2011) Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomedicine 6: 241-247.
13. Williams AC, Barry BW(2012) Penetration enhancers. Adv Drug Deliv Rev doi: 10.1016/j.addr.2012.09.032.
14. Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L (2009) Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 19:155-162.